Your Weight Health

Weight health is important. If you look good you feel good. When your body weight increases so does your health risk. Conditions such as heart disease, strokes, circulation impairment, decreased fertility, depression, anxiety and many other conditions become more prevalent, especially in minority populations. The Center for Disease Control uses Body Mass Index (BMI)  to classify weight. Our body stores of adipose tissue aka fat stores are calculated using a person's weight and height in inches.

​

BMI Ranges 

• BMI is 18.5 to <25, it falls within the healthy weight range.

• If your BMI is 25.0 to <30, it falls within the overweight range.

• If your BMI is 30.0 or higher, it falls within the obesity range.

• If your BMI is 40.0 or higher, it falls within the severely or morbid obese range.

BMI ranges above 30 are concerning  considering the ramifications on the various body systems.  

 

Medications in a class called GLP-1 Agonist have been approved for the treatment of obesity. These medications have been around for many years and it was  primarily used in the treatment of diabetes. Recently it has been approved for treatment of obesity. Medications like Semeglutide,Wegovy, trizipitide, are all examples of injectable GLP-1 medications. GLP-1 medications mimic a  hormone in your body that aids in the control of blood glucose levels. It has been helpful in normalizing blood sugars, decreasing blood pressure ranges and offers some protectivity to the heart. An added benefit was that weight loss occurred while on the medications. Today these medications are highly sought after to help with weight loss because of its publicized sucess. 

​

Like any medication, GLP-1 agonists come with potential risks and side effects. Some of these risks include gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. Additionally, there have been concerns about pancreatitis and pancreatic cancer associated with the long-term use of GLP-1 agonists, although the evidence is still being studied. Furthermore, there may be an increased risk of gallbladder problems and kidney issues for some individuals. Any provider prescribing a GLP-1 medication should be checking their patients blood work at least every 3 months to assess for any changes in the patient's condition. These medications should be used with the caveat that it is to be used in conjunction to clean a healthy diet and some form of exercise.  It's important for patients considering GLP-1 agonists for weight loss to discuss these potential risks with their healthcare provider and weigh them against the benefits before consideration.

​

​

References

CDC. Defining Adult Overweight & Obesity.

https://www.cdc.gov/obesity/basics/adult-defining.html#:~:text=If%20your%20BMI%20is%2018.5,falls%20within%20the%20obesity%20range.

​

​

March 2024

​

​

 

​

​